CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(11): E1717-E1724
DOI: 10.1055/a-1264-7206
Original article

Feasibility and safety study of 22-gauge endoscopic ultrasound (EUS) needles for portal vein sampling in a swine model

Kenneth Park
1   Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California
,
Daniel Lew
1   Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California
,
Christopher Chapman
2   University of Chicago Medical Center, Center for Endoscopic Research and Therapeutics, Chicago, Illinois, United States
,
Ashley Wachsman
1   Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California
,
Matthew Bloom
3   Cedars-Sinai Medical Center – Surgery, Los Angeles, California, United States
,
Liiana Bancila
1   Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California
,
Rachel Perry
1   Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California
,
Qiang Wang
1   Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California
,
Laith Jamil
4   William Beaumont Hospital – Royal Oak, Gastroenterology and Hepatology, Royal Oak, Michigan, United States
,
Stephen Pandol
1   Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California
,
Simon Lo
1   Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California
› Author Affiliations

Abstract

Background and study aims Endoscopic ultrasound (EUS) has been used for portal vein sampling in patients with pancreaticobiliary cancers for enumerating circulating tumor cells but is not yet a standard procedure. Further evaluation is needed to refine the methodology. Therefore, we evaluated the feasibility and safety of 19-gauge (19G) versus a 22-gauge (22 G) EUS fine-needle aspiration needles for portal vein sampling in a swine model.

Methods Celiotomy was performed on two farm pigs. Portal vein sampling occurred transhepatically. We compared 19 G and 22 G needles coated interiorly with saline, heparin or ethylenediaminetetraacetic acid (EDTA). Small- (10 mL) and large- (25 mL) volume blood collections were evaluated. Two different collection methods were tested: direct-to-vial and suction syringe. A bleeding risk trial for saline-coated 19 G and 22 G needles was performed by puncturing the portal vein 20 times. Persistent bleeding after 3 minutes was considered significant.

Results All small-volume collection trials were successful except for 22 G saline-coated needles with direct-to-vial method. All large-volume collection trials were successful when using suction syringe; direct-to-vial method for both 19 G and 22 G needles were unsuccessful. Collection times were shorter for 19 G vs. 22 G needles for both small and large-volume collections (P < 0.05). Collection times for saline-coated 22 G needles were longer compared to heparin/EDTA-coated (P < 0.05). Bleeding occurred in 10 % punctures with 19 G needles compared to 0 % with 22 G needles.

Conclusion The results of this animal study demonstrate the feasibility and the safety of using 22 G needles for portal vein sampling and can form the basis for a pilot study in patients.



Publication History

Received: 29 May 2020

Accepted: 20 August 2020

Article published online:
22 October 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7-34
  • 2 Jani BS, Rzouq F, Saligram S. et al. Endoscopic ultrasound-guided fine-needle aspiration of pancreatic lesions: a systematic review of technical and procedural variables. N Am J Med Sci 2016; 8: 1-11
  • 3 Huang JY, Samarasena JB, Tsujino T. et al. EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study. Gastrointest Endosc 2017; 85: 996-1001
  • 4 Lai L, Poneros J, Santilli J. et al. EUS-guided portal vein catheterization and pressure measurement in an animal model: a pilot study of feasibility. Gastrointest Endosc 2004; 59: 280-283
  • 5 Catenacci DV, Chapman CG, Peng X. et al. Acquisition of portal venous circulating tumor cells from patients with pancreaticobiliary cancers by endoscopic ultrasound. Gastroenterology 2015; 149: 1794-1803 e4
  • 6 Lin E, Cao T, Nagrath S. et al. Circulating tumor cells: diagnostic and therapeutic applications. Annu Rev Biomed Eng 2018; 20: 329-352
  • 7 Massague J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature 2016; 529: 298-306
  • 8 Cristofanilli M, Budd GT, Ellis MJ. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-791
  • 9 Cohen SJ, Punt CJA, Iannotti N. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26: 3213-3221
  • 10 Pachmann K, Camara O, Kavallaris A. et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 2008; 26: 1208-15
  • 11 Hao SJ, Wan Y, Xia Y. et al. Size-based separation methods of circulating tumor cells. Adv Drug Deliv Rev 2018; 125: 3-20
  • 12 Heitzer E, Haque IS, Roberts CES. et al. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet 2019; 20: 71-88
  • 13 Rossi G, Ignatiadis M. Promises and pitfalls of using liquid biopsy for precision medicine. Cancer Res 2019; 79: 2798-2804
  • 14 Kurihara T, Itoi T, Sofuni A. et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreat Surg 2008; 15: 189-195
  • 15 Tien YW, Kuo H, Ho B. et al. A high circulating tumor cell count in portal vein predicts liver metastasis from periampullary or pancreatic cancer: a high portal venous CTC count predicts liver metastases. Medicine (Baltimore) 2016; 95: e3407
  • 16 Rahbari NN, Bork U, Kircher A. et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann Surg Oncol 2012; 19: 2195-2202
  • 17 Liu X, Li C, Li J. et al. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer. J Cancer 2018; 9: 2038-2045
  • 18 Levy MJ, Kipp BR, Milosevic D. et al. Analysis of cell-free DNA to assess risk of tumoremia following endoscopic ultrasound fine-needle aspiration of pancreatic adenocarcinomas. Clin Gastroenterol Hepatol 2018; 16: 1632-1640 e1
  • 19 Chapman CG, Waxman I. EUS-guided portal venous sampling of circulating tumor cells. Curr Gastroenterol Rep 2019; 21: 68
  • 20 Schulman AR, Thompson CC, Ryou M. EUS-guided portal pressure measurement using a digital pressure wire with real-time remote display: a novel, minimally invasive technique for direct measurement in an animal model. Gastrointest Endosc 2016; 83: 817-20
  • 21 Wang H, Hara Y, Liu X. et al. Detection and enumeration of circulating tumor cells based on their invasive property. Oncotarget 2015; 6: 27304-27311
  • 22 Magno P, Ko C, Buscaglia JM. et al. EUS-guided angiography: a novel approach to diagnostic and therapeutic interventions in the vascular system. Gastrointest Endosc 2007; 66: 587-591
  • 23 Lamas GA, Boineau R, Goertz C. et al. EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. Am Heart J 2014; 168: 37-44.e5
  • 24 Bowen RA, Remaley AT. Interferences from blood collection tube components on clinical chemistry assays. Biochem Med (Zagreb) 2014; 24: 31-44
  • 25 Pfitzner J. Poiseuille and his law. Anaesthesia 1976; 31: 273-5
  • 26 Neoptolemos JP, Stocken DD, Friess H. et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210
  • 27 Bissolati M, Sandri MT, Burtulo G. et al. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer. Tumour Biol 2015; 36: 991-996